GU NURSES CONNECT powered by COR2ED

Independent Medical Education from COR2ED developed by GU NURSES CONNECT, experts in GenitoUrinary (GU) oncology nursing.

[OncoAlert @OncoAlert]

Get expert insights on the latest data in lung, prostate, GI, and breast cancers presented at #ASCO26 . Renowned medical experts join @COR2EDMedEd in Chicago to share their views on data emerging from the meeting. How will new trial data impact clinical practice? Watch the video updates to find out!

https://t.co/TNY8ovSvTr

@herbloong
@ipreeshagul
@PTarantinoMD

[OncoAlert @OncoAlert]

Lung cancer 🫁 update from #ASCO26
👉 https://t.co/Tik3fC02aR

Renowned lung cancer experts join our collaborators at COR2ED at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC) from Drs Herbert Loong and Isabel Preeshagul, and analysis of other key lung cancer trial data from Prof. Mark Socinski.
#LungCancer #NSCLC #SCLC
@herbloong @ipreeshagul

[GU NURSES CONNECT powered by COR2ED @gunursesconnect]

📣#GUCancer highlights from #ASCO26!

Medical Oncologist Prof. Evan Yu shares his expert insights on key #ProstateCancer #trialdata from #PROTEUS & #TALAPRO-3

How will these data impact clinical practice? Watch his video to find out!

🤝 Programme endorsed by @WarOnCancer

📺See more updates from @ASCO in #HER2-mutant #NSCLC, #LungCancer, #GIcancer & #BreastCancer
⬇️
https://t.co/rDltQpE5F0

This educational programme is supported by COR2ED
#MedEd #PCSM #urology #CancerNurses #OncTwittter #crpc

[OncoAlert @OncoAlert]

GI and hepatobiliary cancer update from ASCO 2026
Medical oncologist Prof. Hans Prenen joins @COR2EDMedEd in Chicago to share his expert insights on the latest data in colorectal, pancreatic, and liver cancers presented at ASCO 2026. How will late-breaking data impact clinical practice? Watch his video update to find out.

https://t.co/cJdpVtKQUF

[OncoAlert @OncoAlert]

Breast Cancer Update from ASCO 2026 : Watch Dr @PTarantinoMD joins @COR2EDMedEd in Chicago to share his views on the latest breast cancer data emerging from ASCO 2026. How will new developments impact clinical practice? Watch his update to find out!

https://t.co/SAFoLcxl4V

[OncoAlert @OncoAlert]

Dear Colleagues at #ASCO26
Get expert insights on new #ProstateCancer data emerging from ASCO 2026. Prof. Evan Yu joins @COR2EDMedEd live in Chicago to share his views on how new trial data presented at the meeting could impact the clinical management of patients with prostate cancer. Watch his conference update now.

Watch here👉 https://t.co/OouXnsouqm

[GU NURSES CONNECT powered by COR2ED @gunursesconnect]

📣#GUCancer highlights from #ASCO26!

Medical Oncologist Prof. Evan Yu shares his expert insights on key #ProstateCancer #trialdata from #PROTEUS & #TALAPRO-3

How will these data impact clinical practice? Watch his video to find out!

🤝 Programme endorsed by @WarOnCancer

📺See more updates from @ASCO in #HER2-mutant #NSCLC, #LungCancer, #GIcancer & #BreastCancer
⬇️
https://t.co/rDltQpE5F0

This educational programme is supported by COR2ED
#MedEd #PCSM #urology #CancerNurses #OncTwittter #crpc

[OncoAlert @OncoAlert]

Lung cancer 🫁 update from #ASCO26
👉 https://t.co/TZS21R524b

Renowned lung cancer experts join our collaborators at @COR2EDMedEd at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC) from Drs Herbert Loong and Isabel Preeshagul, and analysis of other key lung cancer trial data from Prof. Mark Socinski.
#LungCancer #NSCLC #SCLC
@herbloong @ipreeshagul

[COR2ED @COR2EDMedEd]

📢 #ASCO26 is nearly here, keep a look out for our conference update!

In this video, Dr @ipreeshagul introduces the medical experts who will be joining us at ASCO

➡️Dr @herbloong: 𝘏𝘌𝘙2-mutant NSCLC (along with Dr Preeshagul)

➡️Prof. @MarkSocinski: #NSCLC / #LungCancer

➡️Prof. Evan Yu: #ProstateCancer

➡️Prof. @HPrenen: #GIcancer: #HCC, #LiverCancer, #CRC, #PanCan

➡️ Dr @PTarantinoMD: #BreastCancer

🎬 Keep checking back to see the videos as soon as they’re released: https://t.co/kSgc3cEdxs

𝘏𝘌𝘙2-mutant NSCLC update supported by an Independent Educational Grant from Bayer. All other updates supported by COR2ED

#MedEd #OncTwitter #OncMedEd

[GU NURSES CONNECT powered by COR2ED @gunursesconnect]

May is #OncologyNursingMonth

We want to recognise #cancernurses around the world, working tirelessly to provide the best care for their patients

Thank you for all you do! 💐

From @COR2EDMedED, @ginursesconnect and GU NURSES CONNECT

#IND26 #OncologyNursing

[GU NURSES CONNECT powered by COR2ED @gunursesconnect]

Recap from #ESMO25: Prof. Viktor Grünwald discusses emerging data in advanced renal cell carcinoma and potential implications for clinical practice.

Watch the video covering LenCabo, KEYMAKER-U03, CLEAR & [68 Ga]Ga-DPI-4452 (CAIX) imaging here : https://t.co/6SHjE4XU79

#MedEd #GUOncology

This programme is financially supported by an independent educational grant from Eisai Europe Limited. Eisai has financially contributed towards this material as a sponsor and has had no influence in its organisation or creation.

[GU NURSES CONNECT powered by COR2ED @gunursesconnect]

Check out this interactive patient case with clear takeaways for managing early treatment intensification for mCRPC patients in routine practice

#MedEd

[GU CONNECT powered by COR2ED @guconnectinfo]

Do you treat pts w/ mCRPC and know when to consider early treatment intensification?

📺 Patient case video and ‘SHARE’ communication framework for you to use in your clinical practice

>> From Uro-Oncologist Prof. Gunhild von Amsberg

PART 2 OF THE HIGHLIGHTS VIDEO IN THIS POST!
Check out Part 1 in our previous post 👀

~ Endorsed by Urobel & @ZEROCancer ~

Supported by an Independent Educational Grant from AstraZeneca

#MedEd #PCSM

[GU NURSES CONNECT powered by COR2ED @gunursesconnect]

Prof. Viktor Grünwald shares key insights from ESMO 2025 on emerging data in advanced renal cell carcinoma.

Highlights include evolving first- and later-line strategies, triplet regimens, and tumour-specific imaging in clear cell RCC.

Watch the full video update on YouTube here:
https://t.co/VoqexSWAZN

#RCC #RenalOncology #MedEd

Supported by an independent educational grant from Eisai Europe Limited.

[GU NURSES CONNECT powered by COR2ED @gunursesconnect]

We are proud to share that more than 50,000 HCPs around the world follow @COR2EDMedEd's programmes to stay up to date with the latest science, and provide their patients with the best possible care 🎉

~ GU NURSES CONNECT is an initiative of COR2ED ~

👏 Over 25k HCPs subscribe to the COR2ED YouTube channel to see educational videos as soon as they're released

👏 More than 25k followers stay up to date with #MedEd on the COR2ED social media channels on X, LinkedIn, Instagram, and BlueSky

Are you part of our community yet?

🎓 Follow us for engaging videos, podcasts, publications, micro learnings, and more!

Our programmes are developed by renowned medical experts and endorsed by Medical Societies & Patient Advocacy Groups ✅

Come and follow us on YouTube! https://t.co/j7Bu1m6ftc

#medicaleducation #MedTwitter #OncTwitter

[GU NURSES CONNECT powered by COR2ED @gunursesconnect]

In this interactive mCRPC case study from Prof. Gunhild von Amsberg for @guconnectinfo you’ll learn how early treatment intensification with a PARPi plus ARPI can support improved outcomes.

#ProstateOncology #PCSM

[GU CONNECT powered by COR2ED @guconnectinfo]

New patient case video! 📺

Shared decision-making for mCRPC patients: PART 2

Uro-Oncologist Prof. Gunhild von Amsberg continues to explore early treatment intensification with a PARPi plus ARPI combination

-> You’ll also discover the 5-step SHARE Communication Framework to support shared decision-making with pts

-> (watch Part 1 of the video in our last post!)

Endorsed by Urobel & @ZEROCancer

Supported by an Independent Educational Grant from AstraZeneca

#MedEd #PCSM

[GU NURSES CONNECT powered by COR2ED @gunursesconnect]

@ViktorGruenwald provides @guconnectinfo with insights into emerging data in advanced renal cell carcinoma from #ESMO25 and discusses their implications for clinical practice

Clink the link to select slides or a video overview

[GU CONNECT powered by COR2ED @guconnectinfo]

>> Reviewing the latest #RCC data from #ESMO25

📺 Prof. @ViktorGruenwald shares his perspective on the latest renal cell carcinoma data presented at the congress

View Prof. Grünwald’s slides & see more updates from ESMO, including #BladderCancer
⬇️
https://t.co/bR4k54mZV8

🤝 Endorsed by @KidneyCancer

This RCC update is supported by an independent educational grant from Eisai Europe Limited. Eisai has financially contributed towards this material as a sponsor and has had no influence in its organisation or creation.

#MedEd

[GU NURSES CONNECT powered by COR2ED @gunursesconnect]

Enhance patient discussions with the SHARE Communication Framework; a straightforward five-step guide to support shared, informed decision-making.

Find out more in this interactive prostate cancer patient-case study video from experts in collaboration with @guconnectinfo

#MedEd #GUOncology

[GU CONNECT powered by COR2ED @guconnectinfo]

📣New! patient case video + shared decision-making tool for pts w/ mCRPC

📺 Discover the SHARE Communication Framework to use with your patients in this patient case video

Video highlights PART 2 in this post (see part 1 in our previous post!)

~ Endorsed by Urobel & @ZEROCancer ~

Supported by an Independent Educational Grant from AstraZeneca

#MedEd #PCSM

[GU NURSES CONNECT powered by COR2ED @gunursesconnect]

🎉 @COR2EDMedEd now has over 20,000 YouTube subscribers! 🎉

GU NURSES CONNECT is an initiative of COR2ED - come and find us on YouTube!

Join over 20k healthcare professionals who follow us on YouTube to stay up to date with high-quality, engaging medical education programmes from world-renowned experts 🎓

Subscribe ▶️ https://t.co/j7Bu1m6ftc

#OncTwitter #MedTwitter #MedEd

[OncoAlert @OncoAlert]

THE #ESMO25 COMPLETE Newsletter by OncoAlert 🚨IS OUT NOW‼️

TO GET IT REGISTER at https://t.co/QFM2SYXqbg OR https://t.co/hwvqbilbLO

5⃣0⃣of our pick of TOP Trials Presented in Berlin🇩🇪Divided by Tumor Type and with great video coverage by our collaborators at @COR2EDMedEd @VJOncology and @high5md

We Are ALL @OncoAlert 🌐
For Colleagues...By Colleagues

#BreastCancer
#BladderCancer
#KidneyCancer
#ProstateCancer
#LungCancer
#ColorectalCancer
#GICancer

@matteolambe
@christine_lovly
@peters_solange
@aftimosp
@E_de_Azambuja
@maryam_lustberg
@stolaney1
@JaniceTNBCmets
@DrChoueiri
@neerajaiims
@PGrivasMDPhD
@sonpavde
@TiansterZhang
@apolo_andrea
@Silke_Gillessen
@AOmlin
@tompowles1
@brian_rini
@CathyEngMD
@BenWestphalen
@agz_eriksson
@HenningWillers
@Icro_Meattini
@OncBrothers
@MKnoll_MD
@AndreasC466
#OncoAlertAF
@nataliagandur
@BRicciutiMD
@HHorinouchi
@FernandoOnco
@ElisaAgostinett
@to_be_elizabeth
@bavilima
@realbowtiedoc
@Erman_Akkus
@Lucarecco
@GaiaGriguolo
@JankovicK
@MarioBalsaMD
@DrMirallas
@GIMedOnc
@OscarTahuahua
@UOzkerim
@DrRishabhOnco
@Onco_Cifu88
@DaisukeKotani